381 related articles for article (PubMed ID: 25418713)
1. Transdermal innovations in diabetes management.
Rao R; Mahant S; Chhabra L; Nanda S
Curr Diabetes Rev; 2014; 10(6):343-59. PubMed ID: 25418713
[TBL] [Abstract][Full Text] [Related]
2. Enhanced transdermal drug delivery techniques: an extensive review of patents.
Rizwan M; Aqil M; Talegaonkar S; Azeem A; Sultana Y; Ali A
Recent Pat Drug Deliv Formul; 2009 Jun; 3(2):105-24. PubMed ID: 19519571
[TBL] [Abstract][Full Text] [Related]
3. Recent Updates on Novel Approaches in Insulin Drug Delivery: A Review of Challenges and Pharmaceutical Implications.
Pandey M; Choudhury H; Yi CX; Mun CW; Phing GK; Rou GX; Singh BJKAAJ; Jhee ANA; Chin LK; Kesharwani P; Gorain B; Hussain Z
Curr Drug Targets; 2018; 19(15):1782-1800. PubMed ID: 29792143
[TBL] [Abstract][Full Text] [Related]
4. Current Advancements in Transdermal Biosensing and Targeted Drug Delivery.
Pandey PC; Shukla S; Skoog SA; Boehm RD; Narayan RJ
Sensors (Basel); 2019 Feb; 19(5):. PubMed ID: 30823435
[TBL] [Abstract][Full Text] [Related]
5. Approaches for breaking the barriers of drug permeation through transdermal drug delivery.
Alexander A; Dwivedi S; Ajazuddin ; Giri TK; Saraf S; Saraf S; Tripathi DK
J Control Release; 2012 Nov; 164(1):26-40. PubMed ID: 23064010
[TBL] [Abstract][Full Text] [Related]
6. Insights into the percutaneous penetration of antidiabetic agents.
Ita K
J Drug Target; 2017 Feb; 25(2):102-111. PubMed ID: 27499038
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive drug delivery technology: development and current status of transdermal drug delivery devices, techniques and biomedical applications.
Akhtar N; Singh V; Yusuf M; Khan RA
Biomed Tech (Berl); 2020 May; 65(3):243-272. PubMed ID: 31926064
[TBL] [Abstract][Full Text] [Related]
8. Engineering approaches to transdermal drug delivery: a tribute to contributions of prof. Robert Langer.
Mitragotri S
Skin Pharmacol Physiol; 2013; 26(4-6):263-76. PubMed ID: 23921113
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of enhancers for transdermal drug delivery.
Mitragotri S
Pharm Res; 2000 Nov; 17(11):1354-9. PubMed ID: 11205727
[TBL] [Abstract][Full Text] [Related]
10. Dermal and transdermal delivery of pharmaceutically relevant macromolecules.
Münch S; Wohlrab J; Neubert RHH
Eur J Pharm Biopharm; 2017 Oct; 119():235-242. PubMed ID: 28647443
[TBL] [Abstract][Full Text] [Related]
11. Advances in transdermal insulin delivery.
Zhang Y; Yu J; Kahkoska AR; Wang J; Buse JB; Gu Z
Adv Drug Deliv Rev; 2019 Jan; 139():51-70. PubMed ID: 30528729
[TBL] [Abstract][Full Text] [Related]
12. Iontophoresis-based transdermal delivery systems.
Kanikkannan N
BioDrugs; 2002; 16(5):339-47. PubMed ID: 12408738
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive and persistent transfollicular drug delivery system using a combination of liposomes and iontophoresis.
Kajimoto K; Yamamoto M; Watanabe M; Kigasawa K; Kanamura K; Harashima H; Kogure K
Int J Pharm; 2011 Jan; 403(1-2):57-65. PubMed ID: 20970487
[TBL] [Abstract][Full Text] [Related]
14. Transdermal delivery of antidiabetic drugs: formulation and delivery strategies.
Ahad A; Al-Saleh AA; Akhtar N; Al-Mohizea AM; Al-Jenoobi FI
Drug Discov Today; 2015 Oct; 20(10):1217-27. PubMed ID: 26100737
[TBL] [Abstract][Full Text] [Related]
15. Innovations in transdermal drug delivery: formulations and techniques.
Tiwary AK; Sapra B; Jain S
Recent Pat Drug Deliv Formul; 2007; 1(1):23-36. PubMed ID: 19075872
[TBL] [Abstract][Full Text] [Related]
16. Microneedles: an emerging transdermal drug delivery system.
Bariya SH; Gohel MC; Mehta TA; Sharma OP
J Pharm Pharmacol; 2012 Jan; 64(1):11-29. PubMed ID: 22150668
[TBL] [Abstract][Full Text] [Related]
17. Permeation enhancer strategies in transdermal drug delivery.
Marwah H; Garg T; Goyal AK; Rath G
Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687
[TBL] [Abstract][Full Text] [Related]
18. Transdermal delivery of methotrexate: past, present and future prospects.
Prasad R; Koul V
Ther Deliv; 2012 Mar; 3(3):315-25. PubMed ID: 22833992
[TBL] [Abstract][Full Text] [Related]
19. Biocompatible nanoparticles and vesicular systems in transdermal drug delivery for various skin diseases.
Carter P; Narasimhan B; Wang Q
Int J Pharm; 2019 Jan; 555():49-62. PubMed ID: 30448309
[TBL] [Abstract][Full Text] [Related]
20. Combinations of nanovesicles and physical methods for enhanced transdermal delivery of a model hydrophilic drug.
Zorec B; Zupančič Š; Kristl J; Pavšelj N
Eur J Pharm Biopharm; 2018 Jun; 127():387-397. PubMed ID: 29581043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
